The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Capromorelin     2-amino-N-[(2R)-1-[(1R)-1- benzyl-8-methyl...

Synonyms: CHEMBL113313, SureCN1147592, CHEBI:282843, KST-1A2791, AC1Q5JMA, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Capromorelin

 

High impact information on Capromorelin

  • L-NAME turned EFS induced relaxations into cholinergic contractions that were enhanced by ghrelin, GHRP-6, and capromorelin [2].
  • RESULTS: Ghrelin, GHRP-6, and capromorelin accelerated gastric emptying in an equipotent manner, with bell-shaped dose-response relationships [2].
  • There was a trend, albeit not significant, for the left ventricular function to recover to a greater extent in CP-424,391-treated rabbits [1].
  • Capromorelin showed enhanced intestinal absorption in rodent models and exhibited superior pharmacokinetic properties, including high bioavailabilities in two animal species [F(rat)=65%, F(dog)=44%] [3].
  • New tert-butyl, picolyl and fluorinated analogues of capromorelin (3), a short-acting growth hormone secretagogue (GHS), were prepared as part of a program to identify long-acting GHSs that increase 24-h plasma IGF-1 levels [4].
 

Gene context of Capromorelin

  • Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue [5].
 

Analytical, diagnostic and therapeutic context of Capromorelin

References

  1. Efficacy of a growth hormone-releasing peptide mimetic in cardiac ischemia/reperfusion injury. MacAndrew, J.T., Ellery, S.S., Parry, M.A., Pan, L.C., Black, S.C. Eur. J. Pharmacol. (2001) [Pubmed]
  2. Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro. Kitazawa, T., De Smet, B., Verbeke, K., Depoortere, I., Peeters, T.L. Gut (2005) [Pubmed]
  3. Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin. Carpino, P.A., Lefker, B.A., Toler, S.M., Pan, L.C., Hadcock, J.R., Cook, E.R., DiBrino, J.N., Campeta, A.M., DeNinno, S.L., Chidsey-Frink, K.L., Hada, W.A., Inthavongsay, J., Mangano, F.M., Mullins, M.A., Nickerson, D.F., Ng, O., Pirie, C.M., Ragan, J.A., Rose, C.R., Tess, D.A., Wright, A.S., Yu, L., Zawistoski, M.P., DaSilva-Jardine, P.A., Wilson, T.C., Thompson, D.D. Bioorg. Med. Chem. (2003) [Pubmed]
  4. Discovery and biological characterization of capromorelin analogues with extended half-lives. Carpino, P.A., Lefker, B.A., Toler, S.M., Pan, L.C., Hadcock, J.R., Murray, M.C., Cook, E.R., DiBrino, J.N., DeNinno, S.L., Chidsey-Frink, K.L., Hada, W.A., Inthavongsay, J., Lewis, S.K., Mangano, F.M., Mullins, M.A., Nickerson, D.F., Ng, O., Pirie, C.M., Ragan, J.A., Rose, C.R., Tess, D.A., Wright, A.S., Yu, L., Zawistoski, M.P., Pettersen, J.C., DaSilva-Jardine, P.A., Wilson, T.C., Thompson, D.D. Bioorg. Med. Chem. Lett. (2002) [Pubmed]
  5. Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue. Pan, L.C., Carpino, P.A., Lefker, B.A., Ragan, J.A., Toler, S.M., Pettersen, J.C., Nettleton, D.O., Ng, O., Pirie, C.M., Chidsey-Frink, K., Lu, B., Nickerson, D.F., Tess, D.A., Mullins, M.A., MacLean, D.B., DaSilva-Jardine, P.A., Thompson, D.D. Endocrine (2001) [Pubmed]
 
WikiGenes - Universities